Increased mitochondrial mutation heteroplasmy induces aging phenotypes in pluripotent stem cells and their differentiated progeny
Aging Cell · 2025
DOI: 10.1111/acel.14402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Amy R Vandiver und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, U…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, DNA, Mitochondrial, Mutation, Cellular Senescence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: California Institute for Regenerative Medicine, NIA NIH HHS, NIH award.
Abstract (Originalsprache)
The mitochondrial genome (mtDNA) is an important source of inherited extranuclear variation. Clonal increases in mtDNA mutation heteroplasmy have been implicated in aging and disease, although the impact of this shift on cell function is challenging to assess. Reprogramming to pluripotency affects mtDNA mutation heteroplasmy. We reprogrammed three human fibroblast lines with known heteroplasmy for deleterious mtDNA point or deletion mutations. Quantification of mutation heteroplasmy in the resulting 76 induced pluripotent stem cell (iPSC) clones yielded a bimodal distribution, creating three sets of clones with high levels or absent mutation heteroplasmy with matched nuclear genomes. iPSC clones with elevated deletion mutation heteroplasmy show altered growth dynamics, which persist in iPSC‐derived progenitor cells. We identify transcriptomic and metabolic shifts consistent with increased investment in neutral lipid synthesis as well as increased epigenetic age in high mtDNA deletion mutation iPSC, consistent with changes occurring in cellular aging. Together, these data demonstrate that high mtDNA mutation heteroplasmy induces changes occurring in cellular aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
- Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, California, USA.
- Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
- Department of Biology, California State University Northridge, California, USA.
- Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
- Division of Geriatrics, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
ORCID-Profile: Amy R Vandiver, Mary T Doan, Jonathan Wanagat
Förderung
- California Institute for Regenerative Medicine
- NIA NIH HHS
- NIH award
- NIH HHS
- Melanoma Research Alliance
- NIAID NIH HHS
- Dermatology Foundation
- NCI NIH HHS
Zitieren
APA
Vandiver, A. R., Torres, A., Sanden, A., Nguyen, T. L., Gasilla, J., Doan, M. T., Martirosian, V., Hoang, A., Wanagat, J., & Teitell, M. A. (2025). Increased mitochondrial mutation heteroplasmy induces aging phenotypes in pluripotent stem cells and their differentiated progeny. Aging Cell. https://doi.org/10.1111/acel.14402
Vancouver
Vandiver AR, Torres A, Sanden A, Nguyen TL, Gasilla J, Doan MT, et al. Increased mitochondrial mutation heteroplasmy induces aging phenotypes in pluripotent stem cells and their differentiated progeny. Aging Cell. 2025. doi:10.1111/acel.14402
BibTeX
@article{Vandiver2025,
author = {Vandiver, Amy R and Torres, Alejandro and Sanden, Amberly and Nguyen, Thang L and Gasilla, Jasmine and Doan, Mary T and Martirosian, Vahan and Hoang, Austin and Wanagat, Jonathan and Teitell, Michael A},
title = {Increased mitochondrial mutation heteroplasmy induces aging phenotypes in pluripotent stem cells and their differentiated progeny},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.14402}
}
EUVIMED